FDA recalls more than 2 million baked goods over concerns of listeria contamination
The recall, which impacts approximately 2 million baked goods, was issued for products manufactured by FGF Brands over ...
Health groups sound alarm on missing CDC, FDA data
Prominent health care organizations urge the Trump administration to restore important data sets on the Centers for Disease ...
US FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections
AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
Broccoli sold at Walmart recalled in 20 states now labeled deadly by FDA
Last year, California-based grocery producer Braga Fresh voluntarily issued a precautionary recall of 12-ounce washed and ...
FDA labels broccoli sold at Walmart as deadly. See where it was sold and what you should do
The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the ...
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
FDA labels broccoli sold at Walmart as deadly. See what California stores sell it
The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the ...
FDA recalls more than 2 million cases of doughnuts
The FDA recalled 60 doughnut products, totaling more than 2 million cases, for potential listeria contamination. The ...
Supplement Recall Update as FDA Sets Highest Risk Level
A weight loss supplement has been given the FDA's highest recall classification after being pulled from shelves in December.
More than 2M doughnut products recalled nationwide over listeria risk: FDA
The Food and Drug Administration has classified a recall of 60 different doughnut products to its second-highest level, the agency announced earlier this week in an update to its website.
fingerlakes119h
FDA approves first new non-opioid painkiller in 20 years
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
Targeted Oncology2d
FDA Grants Key Oncology Approvals and Designations in January 2025
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...